合成生命的倫理觀: 有所為，有所不為

The Ethics of Synthetic Life: To Do or Not To Do

Authors

  • 張新慶 (Xinqing ZHANG) 中國北京協和醫學院 (Peking Union Medical College, CHINA)

DOI:

https://doi.org/10.24112/ijccpm.91505

Keywords:

合成生命, 倫理治理, 道家, 風險, 受益分析

Abstract

LANGUAGE NOTE | Document text in Chinese; abstract also in English.

合成生命挑戰了傳統的生命觀念。人類社會要慎重對待合成生物學研究和應用，但不應對合成生命下道德禁令。鑒於合成生命存在較大的風險，既要強調科學家的自律，有所不為，又要加強外部監管。鑒於合成生命存在巨大的潛在利益，公正合理地“有所為”也是必要的。為有效處理與解決合成生命所遇到的倫理—政策問題，中國應儘快醞釀建立一種科學—倫理審查制度和機制。

Modern biotechnology that creates living organisms challenge the traditional definition of life. This paper argues that although we should be very cautious when using synthetic biology, it would be ethically wrong and practically unwise to resist the new biotechnology all together. Daoism is used to discuss the dilemma between being natural (ziran) and being artificial (renwei). Moreover, Daoism calls for the Chinese science community to develop an ethical-regulatory framework to deal with both the potential of biotechnological research and its risks. The paper urges that if we decide to proceed with biotechnology, relevant factors concerning bio-safety and bio-security must be addressed immediately in China.

DOWNLOAD HISTORY | This article has been downloaded 350 times in Digital Commons before migrating into this platform.

Downloads

Download data is not yet available.

Downloads

Published

2011-01-01

How to Cite

ZHANG, X. (2011). 合成生命的倫理觀: 有所為，有所不為: The Ethics of Synthetic Life: To Do or Not To Do. International Journal of Chinese &Amp; Comparative Philosophy of Medicine, 9(2), 43–59. https://doi.org/10.24112/ijccpm.91505

Issue

Vol. 9 No. 2 (2011)

Section

Articles

License

Copyright (c) 2011 International Journal of Chinese & Comparative Philosophy of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The CC BY-NC 4.0 license permits use, distribution and reproduction in any medium, provided the original work is properly cited and not used for commercial purposes. Copyright on any article is retained by the author(s) and the publisher(s).